Whittier Trust Co. of Nevada Inc. Raises Stock Position in Infosys Limited (NYSE:INFY)

Whittier Trust Co. of Nevada Inc. lifted its stake in shares of Infosys Limited (NYSE:INFY) by 158.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,798 shares of the technology company’s stock after buying an additional 6,003 shares during the quarter. Whittier Trust Co. of Nevada Inc.’s holdings in Infosys were worth $215,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of INFY. BHK Investment Advisors LLC raised its position in Infosys by 2.3% in the 4th quarter. BHK Investment Advisors LLC now owns 22,785 shares of the technology company’s stock valued at $499,000 after purchasing an additional 507 shares during the last quarter. Outlook Wealth Advisors LLC raised its position in Infosys by 2.8% in the 4th quarter. Outlook Wealth Advisors LLC now owns 18,405 shares of the technology company’s stock valued at $403,000 after purchasing an additional 508 shares during the last quarter. GAMMA Investing LLC raised its position in Infosys by 14.2% in the 4th quarter. GAMMA Investing LLC now owns 4,496 shares of the technology company’s stock valued at $99,000 after purchasing an additional 560 shares during the last quarter. Flagship Harbor Advisors LLC raised its position in Infosys by 6.2% in the 4th quarter. Flagship Harbor Advisors LLC now owns 11,026 shares of the technology company’s stock valued at $242,000 after purchasing an additional 641 shares during the last quarter. Finally, Atomi Financial Group Inc. raised its position in Infosys by 1.7% in the 4th quarter. Atomi Financial Group Inc. now owns 38,263 shares of the technology company’s stock valued at $839,000 after purchasing an additional 655 shares during the last quarter. Hedge funds and other institutional investors own 16.20% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently commented on INFY shares. Hsbc Global Res upgraded shares of Infosys from a “hold” rating to a “strong-buy” rating in a research report on Monday, December 9th. CLSA upgraded shares of Infosys from a “hold” rating to an “outperform” rating in a research report on Friday, March 7th. Guggenheim restated a “neutral” rating on shares of Infosys in a research report on Friday, January 17th. HSBC upgraded shares of Infosys from a “hold” rating to a “buy” rating in a research report on Monday, December 9th. Finally, StockNews.com downgraded shares of Infosys from a “buy” rating to a “hold” rating in a research report on Thursday. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Infosys has an average rating of “Hold” and an average target price of $19.70.

Infosys Stock Up 1.5 %

NYSE:INFY opened at $18.34 on Monday. Infosys Limited has a fifty-two week low of $16.04 and a fifty-two week high of $23.81. The stock has a market cap of $75.96 billion, a PE ratio of 23.21, a price-to-earnings-growth ratio of 3.50 and a beta of 1.01. The firm’s fifty day simple moving average is $20.81 and its 200-day simple moving average is $21.89.

Infosys (NYSE:INFY) last posted its quarterly earnings results on Thursday, January 16th. The technology company reported $0.19 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.19. Infosys had a net margin of 17.28% and a return on equity of 31.60%. During the same quarter in the previous year, the firm posted $0.18 EPS. Equities analysts anticipate that Infosys Limited will post 0.74 earnings per share for the current year.

About Infosys

Infosys Ltd. is a digital services and consulting company, which engages in the provision of end-to-end business solutions. It operates through the following segments: Financial Services, Retail, Communication, Energy, Utilities, Resources, and Services, Manufacturing, Hi-Tech, Life Sciences, and All Other.